首页> 外文期刊>Retina >Surgical outcomes of epiretinal membranes associated with combined hamartoma of the retina and retinal pigment epithelium.
【24h】

Surgical outcomes of epiretinal membranes associated with combined hamartoma of the retina and retinal pigment epithelium.

机译:与视网膜和视网膜色素上皮联合错构瘤相关的视网膜前膜的手术结局。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: To determine the surgical outcomes of epiretinal membranes associated with combined hamartoma of the retina and retinal pigment epithelium after pars plana vitrectomy and membrane peeling with or without assistance of autologous plasmin enzyme. METHODS: Retrospective review of 11 pediatric eyes that underwent pars plana vitrectomy with membrane peeling with or without autologous plasmin enzyme. Preoperative and postoperative assessments of visual function and retinal architecture were performed by indirect ophthalmoscopy, optical coherence tomography imaging, fundus photography, and measurement of visual acuity. RESULTS: The mean age of the patients was 4.6 years (range, 1-14). Mean follow-up was 15.6 months (range, 6-42 months). The lesions were located solely in the macula in 8 of 11 (73%) patients and in the macula and posterior pole in 3 of 11 (27%) patients. Of the 11 eyes, 6 were preoperatively injected with autologous plasmin enzyme to assist in removal of the posterior hyaloid. All 11 patients (100%) had complete macular reattachment postoperatively. Eight of 11 (73%) showed improved visual acuity postoperatively, and 3 of 11 showed stabilized vision. Eight eyes required only one surgery. Four eyes (36.6%) had recurrences of epiretinal membrane, and three of these eyes required additional surgery. Of the eyes with preoperative plasmin injection, 4 of 6 (66%) showed an improvement in visual acuity whereas 2 of 6 (33%) showed stabilization of visual acuity. Four of five without plasmin showed visual improvement, and one of five had stabilization of vision. CONCLUSION: In the pediatric population, pars plana vitrectomy with membrane peeling with or without the use of autologous plasmin enzyme for epiretinal membrane associated with combined hamartomas of the retina and retinal pigment epithelium can result in improved retinal architecture and visual acuity. Visual acuity may improve despite recurrence of the epiretinal membrane.
机译:目的:确定玻璃体切除术和膜剥离后是否伴有自体纤溶酶的伴有视网膜和视网膜色素上皮合并错构瘤的视网膜前膜相关手术结果。方法:回顾性分析11例小儿玻璃体切除术,伴有或无自体纤溶酶的膜剥离术。通过间接检眼镜,光学相干断层扫描成像,眼底照相和视敏度测量对术前和术后的视觉功能和视网膜结构进行评估。结果:患者的平均年龄为4.6岁(范围1-14)。平均随访15.6个月(范围6-42个月)。 11位患者中有8位(73%)仅位于黄斑内,而11位患者中有3位(27%)仅位于黄斑和后极。在11只眼中,有6只在术前注射了自体纤溶酶,以帮助去除后玻璃体。所有11例患者(100%)术后均完全黄斑复位。 11人中有8人(73%)术后视力得到改善,11人中有3人视力稳定。八只眼睛只需要进行一次手术。四只眼(36.6%)的视网膜前膜复发,其中三只眼需要额外的手术。术前注射纤溶酶的眼中,有6人中有4人(66%)的视力有所改善,而6人中有2人(33%)的视力却稳定了。没有纤溶酶的五分之四的人视觉改善,五分之一的人视力稳定。结论:在儿科人群中,进行或不采用自体纤溶酶对与视网膜和视网膜色素上皮联合错构瘤相关的视网膜上膜进行平面膜玻璃体切除术可以改善视网膜结构和视敏度。尽管视网膜前膜复发,但视力可能会改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号